Laurie Elit

7.1k total citations
143 papers, 3.6k citations indexed

About

Laurie Elit is a scholar working on Reproductive Medicine, Obstetrics and Gynecology and Epidemiology. According to data from OpenAlex, Laurie Elit has authored 143 papers receiving a total of 3.6k indexed citations (citations by other indexed papers that have themselves been cited), including 59 papers in Reproductive Medicine, 53 papers in Obstetrics and Gynecology and 43 papers in Epidemiology. Recurrent topics in Laurie Elit's work include Ovarian cancer diagnosis and treatment (54 papers), Endometrial and Cervical Cancer Treatments (53 papers) and Cervical Cancer and HPV Research (40 papers). Laurie Elit is often cited by papers focused on Ovarian cancer diagnosis and treatment (54 papers), Endometrial and Cervical Cancer Treatments (53 papers) and Cervical Cancer and HPV Research (40 papers). Laurie Elit collaborates with scholars based in Canada, United States and Cameroon. Laurie Elit's co-authors include Michael Fung‐Kee‐Fung, Amit M. Oza, Hal W. Hirte, Kristina Trim, Jason Dodge, Anthony Fyles, Himu Lukka, Alice Lytwyn, Tom Oliver and Clare J. Reade and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Cancer.

In The Last Decade

Laurie Elit

140 papers receiving 3.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Laurie Elit Canada 32 1.4k 1.2k 874 600 600 143 3.6k
Annekathryn Goodman United States 36 2.0k 1.4× 2.0k 1.6× 1.1k 1.2× 783 1.3× 730 1.2× 193 4.4k
Jubilee Brown United States 32 1.6k 1.1× 1.2k 1.0× 877 1.0× 825 1.4× 408 0.7× 130 3.3k
J. Michael Straughn United States 40 1.4k 0.9× 1.2k 1.0× 1.3k 1.4× 795 1.3× 617 1.0× 192 4.4k
Roy F.P.M. Kruitwagen Netherlands 37 2.3k 1.6× 2.0k 1.7× 1.1k 1.3× 1.7k 2.9× 469 0.8× 178 5.2k
Sarah M. Temkin United States 31 781 0.5× 782 0.6× 868 1.0× 376 0.6× 258 0.4× 131 3.0k
Sarah E. Ferguson Canada 31 1.3k 0.9× 1.6k 1.3× 768 0.9× 540 0.9× 370 0.6× 161 3.0k
Myong Cheol Lim South Korea 34 1.9k 1.3× 1.8k 1.4× 1.1k 1.3× 1.2k 2.0× 820 1.4× 268 4.1k
Thomas C. Randall United States 25 756 0.5× 834 0.7× 548 0.6× 349 0.6× 496 0.8× 83 2.3k
Stephanie V. Blank United States 26 1.5k 1.0× 577 0.5× 1.3k 1.5× 493 0.8× 142 0.2× 165 3.4k
Marcela G. del Carmen United States 47 3.2k 2.2× 2.9k 2.4× 1.4k 1.5× 1.6k 2.6× 1.1k 1.9× 221 6.9k

Countries citing papers authored by Laurie Elit

Since Specialization
Citations

This map shows the geographic impact of Laurie Elit's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Laurie Elit with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Laurie Elit more than expected).

Fields of papers citing papers by Laurie Elit

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Laurie Elit. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Laurie Elit. The network helps show where Laurie Elit may publish in the future.

Co-authorship network of co-authors of Laurie Elit

This figure shows the co-authorship network connecting the top 25 collaborators of Laurie Elit. A scholar is included among the top collaborators of Laurie Elit based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Laurie Elit. Laurie Elit is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Pond, Gregory R., Laurie Elit, Danielle Vicus, et al.. (2024). Safety of vaginal surgery for early-stage cervical cancer: A retrospective multicenter cohort study. European Journal of Surgical Oncology. 50(10). 108518–108518. 1 indexed citations
2.
Schwartz, Lisa, Élysée Nouvet, Olive Wahoush, et al.. (2023). Aid when ‘there is nothing left to offer’: Experiences of palliative care and palliative care needs in humanitarian crises. SHILAP Revista de lepidopterología. 3(2). e0001306–e0001306. 7 indexed citations
5.
Francis, Julie‐Ann, N. Coakley, Laurie Elit, & Helen Mackay. (2017). Systemic Therapy for Recurrent Epithelial Ovarian Cancer: A Clinical Practice Guideline. Current Oncology. 24(6). 540–546. 13 indexed citations
6.
Barbera, Lisa, Lilian T. Gien, Rinku Sutradhar, et al.. (2016). The Added Value of Pathology Review in Vulvar Cancer: Results From a Population-based Cohort Study. International Journal of Gynecological Pathology. 36(2). 107–110. 5 indexed citations
7.
Hirte, Hal W., Erin B. Kennedy, Laurie Elit, & Michael Fung Kee Fung. (2015). Systemic Therapy for Recurrent, Persistent, or Metastatic Cervical Cancer: A Clinical Practice Guideline. Current Oncology. 22(3). 211–219. 20 indexed citations
8.
Elit, Laurie, Monika K. Krzyzanowska, Refik Saskin, et al.. (2012). Sociodemographic factors associated with cervical cancer screening and follow-up of abnormal results.. PubMed. 58(1). e22–31. 31 indexed citations
9.
Covens, Allan, Jason Dodge, Christina Lacchetti, et al.. (2012). Surgical management of a suspicious adnexal mass: A systematic review. Gynecologic Oncology. 126(1). 149–156. 20 indexed citations
10.
Akhtar‐Danesh, Noori, Laurie Elit, & Alice Lytwyn. (2011). Temporal trends in the relative survival among patients diagnosed with ovarian cancer in Canada 1992–2005: A population-based study. Gynecologic Oncology. 123(2). 192–195. 14 indexed citations
11.
Charles, Cathy, Amiram Gafni, & Laurie Elit. (2010). What we know about treatment decision making in ovarian cancer. SHILAP Revista de lepidopterología. 2 indexed citations
12.
Elit, Laurie, Cathy Charles, & Amiram Gafni. (2010). Lo que sabemos acerca de la toma de decisiones en cáncer ovárico. Complutensian Scientific Journals (Complutense University of Madrid). 7(2). 269–286. 2 indexed citations
13.
Sinding, Christina, et al.. (2010). “Playing God because you have to”: Canadian health professionals’ experiences of rationing care in humanitarian and development work. Public Health Ethics. 5 indexed citations
14.
Nimeiri, Halla, Amit M. Oza, Robert J. Morgan, et al.. (2010). A phase II study of sorafenib in advanced uterine carcinoma/carcinosarcoma: A trial of the Chicago, PMH, and California Phase II Consortia. Gynecologic Oncology. 117(1). 37–40. 71 indexed citations
15.
Barbera, Lisa, Laurie Elit, Monika K. Krzyzanowska, Refik Saskin, & Arlene S. Bierman. (2010). End of life care for women with gynecologic cancers. Gynecologic Oncology. 118(2). 196–201. 27 indexed citations
16.
Oza, Amit M., Elizabeth A. Eisenhauer, Laurie Elit, et al.. (2008). Phase II Study of Erlotinib in Recurrent or Metastatic Endometrial Cancer: NCIC IND-148. Journal of Clinical Oncology. 26(26). 4319–4325. 97 indexed citations
17.
Lukka, Himu, Alexandra Chambers, Anthony Fyles, et al.. (2006). Adjuvant radiotherapy in women with stage I endometrial cancer: A systematic review. Gynecologic Oncology. 102(2). 361–368. 18 indexed citations
18.
McLachlin, C. Meg, et al.. (2000). Hybrid Capture Human Papillomavirus Testing as an Adjunct to the Follow-Up of Patients with ASCUS and LGSIL Pap Smears: A Study of a Screening Population. Journal of Lower Genital Tract Disease. 4(1). 12–17. 3 indexed citations
19.
Elit, Laurie. (2000). RETIRED: Surgical Management of an Adnexal Mass Suspicious for Malignancy. Journal SOGC. 22(11). 964–968. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026